@TheARISEstudy

A Multi-centre randomised trial of Early Goal Directed therapy and Usual Care for Patients with severe sepsis

arise.org.au
Joined February 2012
  • Tweets1K
  • Following70
  • Followers695
16Media
Congratulations @spjmacdonald and the ARISE Fluid RCT team for your successful MRFF funding. The exciting work starts now! @GKeijzers_EM @adintheICU @jonoburcham @iculisah @ElissaMilford @First_do_noharm @BellomoRinaldo health.gov.au/ministers/the-…

$35.9 million boost for rare cancers, rare diseases and unmet medical needs

A media release about a $35.9 million Australian Government investment in 17 cutting-edge research projects, including projects to improve the diagnosis and treatment of cancer, improve neonatal...

health.gov.au
1
9
3
19
The ARISE Study retweeted
The New Yorker
@NewYorker22 Mar 2020
“We can learn from the experiences of our colleagues across the planet,” @Atul_Gawande writes, of Singapore’s and Hong Kong’s success in containing the spread of the coronavirus. “The pandemic is global; its lessons are, too.” nyer.cm/98TuTiu

Keeping the Coronavirus from Infecting Health-Care Workers

What Singapore’s and Hong Kong’s success is teaching us about the pandemic.

newyorker.com
17
516
73
785
The ARISE Study retweeted
EMA Journal@EMAJournal15 Feb 2020
What are the current resuscitation practices in patients with #sepsis and hypotension in Australasia? bit.ly/ARISE_Observational #OpenAccess #OriginalResearch @TheARISEstudy @GKeijzers_EM @spjmacdonald @BellomoRinaldo @DrKatyaMay @gabyblech @sandrapeake01 @coggi33 @adintheICU
11
1
14
The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi‐centre observational study describing current practice in Australia and New Zealand onlinelibrary.wiley.com/doi/… #OpenAccess @spjmacdonald @GKeijzers_EM
7
8
The ARISE Study retweeted
EMA Journal@EMAJournal8 Nov 2019
How common are complications after vasopressor infusions via peripheral intravenous catheters? #FreeAccess for 30 days bit.ly/VasopressorReview @GKeijzers_EM @adintheICU @spjmacdonald @sandrapeake01 @Wiley_Health @acemonline
10
10
Come join us @worldcongressic We are running #BASICClinicalResearch 12-13 October For more information and to register aic.cuhk.edu.hk/bcr/faq_bcr.… See you there! Faculty include @ShayMcGuinness1 @DrJohnCMarshall @AndrewDavies66 @ed_litton @adintheICU
InFACT@AcuteCareTrials1 Aug 2019
How is InFACT @AcuteCareTrials building research capacity in low to middle income countries? Have a read here: bit.ly/2Mw4Kx9 #globalhealth @WHO @worldcongressic @gchallenges @AKUGlobal @CCCTG_
6
6
Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press atsjournals.org/doi/abs/10.1…

American Thoracic Society Journals

American Thoracic Society Journals

academic.oup.com
3
2
11
Hot off the press: ARISE Fluids Observational study rationale, methods and analysis plan. Well done team! @EMA @acemonline @UWAresearch @PerkinsComms @TheARISEstudy @GKeijzers_EM @spjmacdonald @WorldSepsisDay @sepsisAU
18
3
32
The ARISE Study retweeted
Gerben Keijzers@GKeijzers_EM23 Jan 2019
The rationale and analysis plan now out on early view! @EMAJournal @TheARISEstudy @CCREM2 @GC_Health @REFRESH_Trial @theamandaharley
2
9
2
19
Paper is now published in print in @yourICM @emfresearch @CCREM2 @GKeijzers_EM @CCRG_Research @BellomoRinaldo @TheARISEstudy links.springernature.com/f/a…~~
7
1
11
Replying to @broomedocs @senthi @GKeijzers_EM
Cannot translate findings from animal models or resource poor to our setting. Secondary analysis of @TheARISEstudy found increased mortality with early pressors. We need a trial @REFRESH_Trial #equipoise #ACEM18 journals.lww.com/shockjourna…
1
7
7
The ARISE Study retweeted
Casey Parker@broomedocs12 Nov 2018
Replying to @spjmacdonald @emfresearch @GKeijzers_EM @CCREM2 @PerkinsComms @GC_Health @TheARISEstudy @REFRESH_Trial
I’m looking forward to being part of this important research #broome #sepsis
1
5
The ARISE Study retweeted
Dr Katya May@DrKatyaMay15 Nov 2018
Replying to @GKeijzers_EM
@GKeijzers_EM presented @REFRESH_Trial results at #GCHResConf @TheARISEstudy @theamandaharley @EpidemicAmy @GC_Health @VanessaDruett @jamieranse
3
1
9
Trial results now published and available in full text view online with thanks @SpringerNature link.springer.com/epdf/10.10…
19
9
31
Pleased to be presenting @REFRESH_Trial at Sepsis2018. Lots of interest. Fluids a hot topic at the meeting. @emfresearch @GKeijzers_EM @CCRG_Research @BellomoRinaldo @CCREM2
10
2
19
The ARISE Study retweeted
Gerben Keijzers@GKeijzers_EM12 Sep 2018
ARISE FLUIDS observational study starting today! @SocraticEM @emfresearch @REFRESH_Trial @TheARISEstudy @GC_Health
11
1
25
The ARISE Study retweeted
Gerben Keijzers@GKeijzers_EM10 Sep 2018
Countdown is on. ARISE FLUIDS observational study on fluid management in sepsis kicking off on world sepsis day (13 sept) in many hospitals in Australia. @emfresearch @REFRESH_Trial @GC_Health @ANZICS_CTG @ACEMFoundation @spjmacdonald @adintheICU
1
9
2
28
We concur xitter.cf/drlmac/status/10058985…
Lewis McLean@drlmac10 Jun 2018
The sepsis fluid resuscitation trial we need in humans: atsjournals.org/doi/pdf/10.1… #sepsis #survingsepsis
2
Surviving sepsis: Are vasopressors or fluids better for resus in adults? Time for a phase III trial? #CTGNoosa2018 @AndrewUdy @sandrapeake01 @BellomoRinaldo
19
1
22
The ARISE Study retweeted
Graeme Duke@drgduke6 Mar 2018
Andrew Udy great presentation on vasopressors from ARISE showing high use and high associated fatality rate 26%, hazrad ratio 1.2 Are early vasopressors harmful or selecting higher @risk group? #CTGNoosa2018
5
5
Load more